Mostrar el registro sencillo del ítem

dc.rights.licenseLicencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacionalspa
dc.contributor.authorUrina-Triana, Miguel
dc.contributor.authorUrina-Jassir, Daniela
dc.contributor.authorUrina-Jassir, Manuel
dc.contributor.authorUrina-Triana, Manuel
dc.date.accessioned2018-03-08T21:05:41Z
dc.date.available2018-03-08T21:05:41Z
dc.date.issued2017
dc.identifier.issn18564550
dc.identifier.urihttp://hdl.handle.net/20.500.12442/1821
dc.description.abstractEn América Latina hacer un análisis del impacto en la prevalencia de hipertensión arterial producto de la participación de la raza negra en su origen es complejo ya que no hay muchos estudios que analicen esta problemática y en particular porque el comportamiento migratorio que originó la presencia de la raza negra en nuestro continente no tuvo el mismo comportamiento en todos los países. Se requiere que se aumenten las estrategias para lograr la detección, aumentar la cobertura y optimizar el tratamiento en los individuos afrodescendientes en Latinoamérica. Se necesitan estudios con suficiente tamaño de muestra para ver las diferencias según género, pureza de la raza, mestizaje, influjo social, migraciones, industrialización y severidad de la hipertensión arterial.spa
dc.description.abstractIn Latin America, an analysis of the impact on the prevalence of arterial hypertension resulting from the participation of the black race in its origin is complex since there are not many studies that analyze this problem and because the migratory behavior that originated the presence of the black race in our continent did not have the same behavior in all countries. Increasing strategies to achieve detection, increase coverage and optimize treatment in Afro-descendant individuals in Latin America are required. Studies with sufficient sample size are needed to see the differences according to gender, race purity, miscegenation, social influence, migrations, industrialization and severity of hypertension.eng
dc.language.isospaspa
dc.publisherCooperativa servicios y suministros 212518 RSspa
dc.sourceRevista Latinoamericana de Hipertensiónspa
dc.sourceVol. 12, No. 5 (2017)spa
dc.source.urihttps://www.redalyc.org/articulo.oa?id=170254309008
dc.subjectHipertensión arterialspa
dc.subjectAfrodescendientesspa
dc.subjectLatinoaméricaspa
dc.subjectAterosclerosisspa
dc.subjectEnfermedad arterial coronariaspa
dc.subjectAfro-descendanteng
dc.subjectLatin Americaneng
dc.subjectAtherosclerosiseng
dc.subjectCoronary artery diseaseeng
dc.titleConsideraciones especiales de la hipertensión arterial sistémica en afrodescendientes de América latinaspa
dc.title.alternativeHypertension among Latin-Americans of African descendants: special considerationseng
dc.typearticlespa
dcterms.referencesRedmond N, Baer HJ, Hicks LS. Health behaviors and racial disparity in blood pressure control in the national health and nutrition examination survey. Hypertension. 2011; 57(3): 383-389.doi:10.1161/HYPERTENSIONAHA.110.161950.eng
dcterms.referencesFuchs F. Why Do Black Americans Have Higher Prevalence of Hypertension? An Enigma Still Unsolved Hypertension. 2011; 57:379-380. doi:10.1161/HYPERTENSIONAHA. 110.163196eng
dcterms.referencesBrewster Li, Kleijnen J, van Montfrans Gert G. Effect of antihypertensive drugs on mortality, morbidity and blood pressure in blacks. Cochrane Database of Systematic Reviews 2015. In: The Cochrane Library, Issue 9, Art. No. CD005183. DOI: 10.1002/14651858.CD005183.pub1eng
dcterms.referencesKrakoff LR, Gillespie RL, Ferdinand KC, Fergus IV, Akinboboye O, Williams KA, et al. Hypertension Recommendations from the Eighth Joint National Committee Panel Members Raise Concerns for Elderly Black and Female Populations. Journal of the American College of Cardiology. 2014; 64(4), 394–402. DOI: 10.1016/j. jacc.2014.06.014eng
dcterms.referencesFlack JM, Sica DA, Bakris G, Brown AL, Ferdinand KC, Grimm RH, et al. Management of high blood pressure in African Americans: management of high blood pressure in blacks: an update of the International Society on Hypertension in Blacks Consensus Statement. Hypertension. 2010; 56:780–800.DOI: 10.1161/ HYPERTENSIONAHA.110.152892eng
dcterms.referencesWright JT Jr, Fine LJ, Lackland DT, Ogedegbe G, Himmelfarb D. Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: the minority view. Ann Intern Med. 2014; 160:499– 504. DOI: 10.7326/M13-2981.eng
dcterms.referencesJames PA, Oparil S, Carter BL, Cushman W, Dennison-Himmelfarb D, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults. Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014; 311:507–520. DOI:10.1001/ jama.2013.284427eng
dcterms.referencesSHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991; 265:3255–3264. DOI:10.1001/jama.1991.03460240051027eng
dcterms.referencesStaessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhäger W, et al. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997; 350:757–764. DOI: 10.1016/S0140- 6736(97)05381-6eng
dcterms.referencesLiu L, Wang JG, Gong L, Staessen JA. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. J Hypertens. 1998; 16:1823–1829. PMID: 9869017eng
dcterms.referencesWang JG, Staessen JA, Gong L, Liu L; for the Systolic Hypertension in China (Syst- China) Collaborative Group. Chinese trial on isolated systolic hypertension. Arch Intern Med. 2000; 160:211–220. DOI:10.1001/archinte.160.2.211eng
dcterms.referencesBeckett N, Peters R, Fletcher A, Staessen J, Liu L, Dumitrascu D, for the HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. Neng
dcterms.referencesJATOS Study Group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res. 2008; 31:2115–2127. DOI: 10.1291/hypres.31.2115eng
dcterms.referencesOgihara T, Saruta T, Rakugi H, Matsuoka H, Shimamoto K Shimada K, et al. Target blood pressure for treatment of isolated systolic hypertension in the elderly: Valsartan in Elderly Isolated Systolic Hypertension Study. Hypertension. 2010; 56:196–202. DOI: 10.1161/HYPERTENSIONAHA.109.146035eng
dcterms.referencesLiu L, Zhang Y, Liu G,Li W, Zhang X, Zanchetti A ,et al. The Felodipine Event Reduction (FEVER) study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients. J Hypertens. 2005; 23:2157–2172. PMID: 16269957eng
dcterms.referencesVerdecchia P, Staessen JA, Angeli F, de Simone G, Achill A, Ganau A, et al. Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomized trial. Lancet. 2009; 374:525– 533. DOI: 10.1016/S0140-6736(09)61340-4eng
dcterms.referencesThe SPS3 Study Group. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet. 2013; 382:507–515. DOI: 10.1016/ S0140-6736(13)60852-1eng
dcterms.referencesPROGRESS Collaborative Group. Randomized trial of a perindopril- based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033–1041. DOI: 10.1016/ S0140-6736(01)06178-5eng
dcterms.referencesReid G. Afro-Latinoamérica 1800-2000. Editorial Iberoamericana Vervuert (Madrid, España) 2007. ISBN:9788484893097spa
dcterms.referencesLizcano F. “Composición Étnica de las Tres Áreas Culturales del Continente Americano al Comienzo del Siglo XXI”. Convergencia Revista de Ciencias Sociales 2005; 38:185-232.spa
dcterms.referencesOrduñez P, Silva LC, Rodriguez MP, Robles S. Prevalence estimates for hypertension in Latin America and the Caribbean: are they useful for surveillance. Rev Panam Salud Pública 2001; 10(4):226-23. PMID: 11715168eng
dcterms.referencesKaplan NM, Victor RG. Kaplan’s Clinical Hypertension.11th ed. Philadelphia, PA: Lipincott Williams & Williams; 2014. ISBN:978-1-451-19013-7eng
dcterms.referencesFuchs FD, Chambless LE, Whelton PK, Nieto FJ, Heiss G. Alcohol consumption and the incidence of hypertension: The Atherosclerosis Risk in Communities Study. Hypertension. 2001; 37:1242–1250. DOI: 10.1161/01.HYP.37.5.1242eng
dcterms.referencesWilson TW, Grim CE. Biohistory of slavery and blood pressure differences in blacks today: a hypothesis. Hypertension. 1991; 17(1 suppl): I122–I128. PMID: 1986989eng
dcterms.referencesKao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, Li M, et al. Family Investigation of Nephropathy and Diabetes Research Group. MYH9 is associated with non-diabetic end-stage renal disease in African Americans. Nat Genet. 2008; 40:1185–1192. DOI: 10.1038/ng.232eng
dcterms.referencesKopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, et al. MYH9 is a major effect risk gene for focal segmental glomerulosclerosis. Nat Genet. 2008; 40:1175–1184.eng
dcterms.referencesTzur S, Rosset S, Shemer R, Yudkovsky G, Selig S, Tarekegn A, et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet. 2010; 128: 345–350. DOI: 10.1007/s00439-010-0861-0eng
dcterms.referencesCenters for Disease Control and Prevention (CDC). Differences in prevalence of obesity among black, white, and Hispanic adults - United States, 2006–2008. MMWR Morb Mortal Wkly Rep. 2009; 58(27):740–744. PMID: 19609247eng
dcterms.referencesAstor BC, Yi S, Hiremath L, Corbin T, Pogue V, Wilkening B, Peterson G, et al. N-Terminal Prohormone Brain Natriuretic Peptide as a Predictor of Cardiovascular Disease and Mortality in Blacks with Hypertensive Kidney Disease: The African American Study of Kidney Disease and Hypertension (AASK). Circulation. 2008; 117:1685-1692 DOI: 10.1161/CIRCULATIONAHA.107.724187eng
dcterms.referencesBurroughs M, Mendes CV, Silva LC, Orduñez P. Usefulness for surveillance of hypertension Prevalence studies in Latin America and the Caribbean: the past 10 years. Rev Panam Salud Publica. 2012; 32(1): 15-20. PMID: 22910720eng
dcterms.referencesKuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1997. JAMA.1994; 272: 205-211.DOI: 10.1001/ jama.1994.03520030047027eng
dcterms.referencesFlegal K, Carroll M, Ogden C, Johnson C. Prevalence and Trends in Obesity Among US Adults, 1999-2000. JAMA.2002; 288:1723- 1727.DOI: 10.1001/ jama.288.14.1723eng
dcterms.referencesBurke GL, Savage PJ, Manolio TA, Sprafka JM, Wagenknecht LE, Sidney S, et al. Correlates of obesity in young black and white women: the CARDIA Study. American Journal of Public Health. 82(12):1621-1625.eng
dcterms.referencesNavarro E, Vargas R. Características epidemiológicas relacionadas con el género en hipertensos de raza negra. Revista Científica Salud Uninorte 2009;25(1):88- 100spa
dcterms.referencesCooper R, Rotimi C, Ataman S, McGee D, Osotimehin B, Kadiri S, et al. The Prevalence of Hypertension in Seven Populations of West African Origin. American Journal of Public Health. 1997; 87(2):160-168. PMCID: PMC1380786eng
dcterms.referencesDressler WW, Balieiro MC, Dos Santos JE. Culture, skin color, and arterial blood pressure in Brazil. Am J Hum Biol. 1999; 11(1):49-59.eng
dcterms.referencesCooper RS, Wolf-Maier K, Luke A, Adeyemo A, Banegas JR, Forrester T, et al. An International Comparative Study of Blood Pressure in Populations of European vs. African Descent. BMC Medicine 2005; 3: 2.DOI:10.1186/1741-7015-3-2eng
dcterms.referencesSantos-Silva DA, Petroski EL, Peres MA. Prehypertension and hypertension among adults in a metropolitan area in Southern Brazil: population-based study. Rev SaudePublica.2012; 46(6):988-98. PMID: 23503537eng
dcterms.referencesOrduñez P, Muñoz JLB, Espinosa-Brito A, Silva LC, Cooper RS. Ethnicity, Education, and Blood Pressure in Cuba. American Journal of Epidemiology. 2005; 162(1):49-56. DOI: 10.1093/aje/kwi163eng
dcterms.referencesOrduñez P, Kaufman JS, Benet M, Morejon A, Silva LC, Shoham DA, et al. Blacks and Whites in the Cuba have equal prevalence of hypertension: confirmation from a new population survey. Bmc Public Health.2013; 13:169. DOI:10.1186/1471-2458-13-169eng
dcterms.referencesSichieri R, Oliveira MC, Pereira RA. High Prevalence of Hypertension among Black and Mulatto Women in a Brazilian Survey. Ethn Dis 2001; 11(3):412-418.PMID: 11572407eng
dcterms.referencesLongo GZ, Neves J, Luciano VM, Peres MA. Prevalence of high blood pressure levels and associated factors among adults in Southern Brazil. Arq Bras Cardiol. 2009; 93(4):387-94, 380-6. PMID: 19936459eng
dcterms.referencesLessa I, Magalhaes L, Araujo MJ, de Almeida Filho N, Aquino E, Oliveira MM. Arterial hypertension in the adult population of Salvador (BA)-Brazil. Arq Bras Cardiol.2006; 87(6):747- 56. DOI: 10.1590/S0066-782X2006001900011eng
dcterms.referencesCooper R, Cutler J, Desvigne-Nickens P, Fortmann SP, Friedman L, Havlik R, et al. Trends and Disparities in Coronary Heart Disease, Stroke, and other Cardiovascular Diseases in the United States - Findings of the National Conference on Cardiovascular Disease Prevention. Circulation. 2000; 102(25):3137-3147.eng
dcterms.referencesLantz PM, Golberstein E, House JS, Morenoff J. Socioeconomic and behavioral risk factors for mortality in a national 19-year prospective study of U.S. adults. Soc Sci Med. 2010; 70(10):1558-66.DOI: 10.1161/01.CIR.102.25.3137eng
dcterms.referencesDANE. Boletín Censo General 2005. Necesidades Básicas Insatisfechas. In: Departamento Administrativo Nacional de Estadísticas (DANE), editor. Bogotá D.C.: Departamento Administrativo Nacional de Estadísticas (DANE); 2005. p. 4.spa
dcterms.referencesLantz PM, House JS, Lepkowski JM, Williams DR, Mero RP, Chen JM. Socioeconomic factors, health behaviors, and mortality - Results from a nationally representative prospective study of US adults. JAMA 1998; 279(21):1703- 1708. DOI:10.1001/jama.279.21.1703eng
dcterms.referencesAdler NE, Newman K. Socioeconomic disparities in health: Pathways and policies. Health Affairs. 2002; 21(2):60-76. PMID: 11900187eng
dcterms.referencesDressler WW, Balieiro MC, Ribeiro RP, Dos Santos JE. Cultural consonance and arterial blood pressure in urban Brazil. Soc Sci Med. 2005;61(3):527-540. DOI: 10.1016/j.socscimed.2004.12.013eng
dcterms.referencesGuerrero-Romero F, Rodriguez-Moran M, Sandoval-Herrera F, Alvarado-Ruiz R. 160 Prevalence of Hypertension in Indigenous Inhabitants of Traditional Communities from the North of Mexico. Journal of Human Hypertension. 2000; 14(9):555- 559. DOI: 10.1038/sj.jhh.1001067eng
dcterms.referencesHollenberg NK, Martínez G, McCullough M, Meinking T, Passan D, Preston M, et al. Aging, acculturation, salt intake, and hypertension in the Kuna of Panama. Hypertension.1997; 29(1):171-176. DOI: 10.1161/01.HYP.29.1.171eng
dcterms.referencesTavares EF, Vieira-Filho JPB, Andriolo A, Sanudo A. Metabolic Profile and Cardiovascular Risk Patterns in an Indigenous Population of Amazonia. Hum Biol. 2003; 75(1):31-46. PMID: 12713144. PMID: 11455998eng
dcterms.referencesCoimbra CE, Jr., Chor D, Santos RV, Salzano FM. Blood pressure levels in Xavante adults from the Pimentel Barbosa Indian Reservation, Mato Grosso, Brazil. Ethn Dis. 2001; 11(2):232-40. PMID: 11455998eng
dcterms.referencesOliveira GF, Oliveira TR, Rodrigues FF, Correa LF, Ikejiri AT, Casulari LA. Prevalence of diabetes mellitus and impaired glucose tolerance in indigenous people from Aldeia Jaguapiru, Brazil. Rev Panam Salud Pública. 2011; 29(5):315-21. PMID: 21709935eng
dcterms.referencesAgostinho SG, Rodrigues D, Pagliaro H, Cano EN, de Souza Lima EE, Baruzzi RG. Metabolic and anthropometric profile of Aruak Indians: Mehinaku, Waura and Yawalapiti in the Upper Xingu, Central Brazil, 2000-2002. Cad Saude Pública. 2007; 23(8):1946-54.DOI:10.1590/S0102-311X2007000800021eng
dcterms.referencesPicon RV, Fuchs FD, Moreira LB, Riegel G, Fuchs SC. Trends in prevalence of hypertension in Brazil: a systematic review with meta-analysis. PLoS One. 2012; 7(10): e48255.DOI: 10.1371/journal.pone.0048255eng
dcterms.referencesOgedegbe G, Shah N, Phillips C, Goldfeld K, Roy J, Guo Y, et al. Comparative effectiveness of angiotensin-converting enzyme inhibitor-based treatment on cardiovascular outcomes in hypertensive blacks versus whites. J Am Coll. 2015; 66: 1124-1133.DOI; 10.1016/j.jacc.2015.07.021.eng
dcterms.referencesHoward G, Lackland D, Kleindorfer D, et al. Racial differences in the impact of elevated systolic blood pressure on stroke risk. JAMA Intern Med 2013; 173:46–51. DOI: 10.1001/2013.jamainternmed.857.DOI: 10.1001/2013.jamainternmed. 857eng
dcterms.referencesTu W, Eckert G, Hannon T, Liu H, Pratt LM, Wagner M, et al. Racial differences in sensitivity of blood pressure to aldosterone. Hypertension. 2014; 63: 1212-1218. DOI; 10.1161/HYPERTENSIONAHA.113.02989eng
dcterms.referencesLuft FC, Miller JZ, Grim CE, Fineberg NS, Christian JC, Daugherty SA, et al. Sodium sensitivity and resistance of blood pressure. Age and race as factors in physiological response. Hypertension. 1991; 17 (suppl 1):1102–1108.eng
dcterms.referencesWeinberger MH. Salt sensitivity of blood pressure in humans. Hypertension. 1996; 27(3 Pt 2):481–490. PMID: 1846122eng
dcterms.referencesPowe C, Evans M, Wenger J, Zonderman A, Berg A, NallsM, et al. Vitamin Dbinding and vitamin D status of blacks Americans and White Americans. N Engl J Med.2013; 369: 1991-2000. DOI; 10.1056/NEJMoa1306357eng
dcterms.referencesWeng, S, Sprague J, Oh J, Riek A, Chin K, Garcia M Et al. Vitamin D deficiency induces high blood pressure and accelerates atherosclerosis in mice. PLoS One. 2013; 8(1): e54625. DOI: 10.1371/journal.pone.0054625eng
dcterms.referencesForman J, Scott J, Drake B, Gonzalez E, Hayden D, Bennett G, et al. Effect of vitamin D supplementation on blood pressure in blacks. Hypertension. 2013; 61:779-785. DOI: 10.1161/HYPERTENSIONAHA.111.00659.eng
dcterms.referencesScisney-Matlock M, Bosworth HB, Giger JN, Strickland OL, Harrison RV, Coverson D, et al. Strategies for implementing and sustaining therapeutic lifestyle changes as part of hypertension management in African Americans. Postgrad Med. 2009; 121:147–159. DOI: 10.3810/pgm.2009.05.2015eng
dcterms.referencesFlack J, Sica D, Bakris G, Brown A, Ferdinand K, Grimm R, et al. ISHIB Consensus Statement. Management of high blood pressure in blacks. Hypertension. 2010; 56:780-800. DOI: 10.1161/HYPERTENSIONAHA.110.152892eng
dcterms.referencesBrewster L, Kleijen J, van Montfrans G. Effect of antihypertensive drugs on mortality, morbidity and blood pressure in blacks. Cochrane Database of Systematic Reviews. In: The Cochrane Library, Issue 9, Art. No. CD005183. DOI: 10.1002/14651858.CD005183.pub1eng
dcterms.referencesWright JT, Dunn JK, Cutler JA, Davis BR, Cushman WC, Ford CE, et al. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and Lisinopril. JAMA. 2005; 293; 1595-608. DOI: 10.1001/ jama.293.13.1595eng
dcterms.referencesThe SPRINT Research Group. Randomized trial of intensive versus standard bloodpressure. N Engl J Med 2015; 373:2103-2116. DOI: 10.1056/NEJMoa1511939eng
dcterms.referencesOrtega LM, Sedki E, Nayer A. Hypertension in the African American population: A succinct look at its epidemiology, pathogenesis and therapy.Nefrologia. 2015; 35(2):139-45. doi: 10.1016/j.nefro.2015.05.014.eng
dcterms.referencesGassman JJ, Greene T, Wright JT Jr, Agodoa L, Bakris G, Beck GJ, et al. Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK). J Am Soc Nephrol. 2003; 14: S154 –S165.DOI: 10.1097/01. ASN.0000070080. 21680.CBeng
dcterms.referencesFlack JM, Nasser SA, Levy PD. Therapy of hypertension in African Americans. Am J Cardiovasc Drugs. 2011; 11:83-92. DOI: 10.2165/11586930-000000000- 00000.eng
dcterms.referencesTask Force of the Latin American Society of Hypertension. Guidelines on the management of arterial hypertension and related comorbidities in Latin America. J Hypertens. 2017; 35(8):1529-1545. DOI: 10.1097/HJH.0000000000001418.eng
dcterms.referencesAlcocer L, Bendersky M, Acosta J, Urina-Triana M. Use of calcium channel Blockers in Cardiovascular Risk Reduction. Issues in Latin America. Am J Cardiovasc Drugs. 2010; 10(3): 143-54.DOI: 10.2165/11536120-000000000-00000.eng
dcterms.referencesCovelli MM. Prevalence of behavioral and physiologic risk factors of hypertension in African American adolescents. Pediatr Nurs. 2007; 33(4):323Y331. PMID: 17907733eng
dcterms.referencesCovelli M, Wood C, Yarandi H. Biologic measures as epidemiological indicators of risk for the development of Hypertension in an African American Adolescent Population. Journal of Cardiovascular Nursing 2012; 27:476-484. DOI: 10.1097/ JCN.0b013e31822f7971eng
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

  • Artículos [1351]
    Artículos científicos evaluados por pares

Mostrar el registro sencillo del ítem